CLDX
Celldex Therapeutics Inc
31.10$
-1.2%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +9.1% | +83.3% | -32.6% | -48.6% | +338.4% | +100.4% | -30.9% | +48.0% | -55.0% | +59.7% | +3.5% | +46.1% | +103.6% | +208.3% | -80.2% | +20.9% | -63.3% | -12.8% | +52.8% | +23.8% | +87.8% | -25.2% | -62.5% | +107.6% | -37.3% | -49.3% | +192.0% | +2.0% | -78.6% | |
| – | – | – | – | – | – | +11.4% | – | – | – | +103.3% | +38.9% | +58.8% | -78.4% | +43.8% | -24.5% | +18.2% | -78.3% | +45.7% | +17.9% | +2,443.7% | -5.7% | -30.9% | -35.8% | -0.3% | +25.3% | +54.3% | +43.5% | +38.6% | – | |
| – | +25.0% | +73.3% | -15.5% | -33.9% | +127.8% | +101.4% | -30.5% | +48.0% | -55.0% | +59.7% | +3.5% | +46.1% | -9.0% | +411.8% | -99.6% | +192.5% | +316.2% | -89.6% | +694.1% | -6,583.3% | – | – | – | – | – | – | – | – | – | |
| – | -11.7% | +7.5% | +38.1% | +36.9% | +100.3% | -31.8% | -31.9% | +38.4% | +1.4% | +28.5% | +2.4% | +42.4% | -0.7% | +5.7% | +17.3% | +46.1% | +42.2% | +54.9% | -4.0% | +2.6% | -6.4% | -30.9% | -35.8% | -5.0% | +40.2% | +44.8% | +43.5% | +38.6% | +49.9% | |
| – | -46.2% | +8.6% | +12.6% | +12.3% | +2.2% | +13.8% | -4.3% | +4.1% | +123,642.8% | +19.5% | +3.2% | +73.5% | -99.9% | -39.1% | -11.4% | +8.4% | +47.8% | +39.3% | +64.1% | +6.3% | -30.5% | -22.9% | -19.9% | -6.3% | +41.7% | +32.7% | +13.7% | +24.7% | +13.6% | |
| – | -29.2% | +14.1% | +34.7% | +19.5% | +65.0% | -24.3% | -22.4% | +24.9% | +7.4% | +24.3% | +2.4% | +48.3% | +5.3% | -5.6% | +5.9% | +34.2% | +42.2% | +47.3% | -71.6% | +8.1% | +1.1% | +161.2% | -84.0% | +77.2% | -20.0% | +56.5% | +22.9% | -11.2% | +649.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | -48.1% | -92.9% | +189.7% | +195.8% | +34.3% | -12.2% | -41.2% | -100.0% | – | – | – | +846.0% | -100.0% | – | -99.4% | +2,497.3% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +704.6% | -101.4% | – | -127.7% | – | – | -208.8% | – | – | -200.0% | – | -102.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | -72.8% | -5,658.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -932.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.